These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30294976)

  • 21. Parkinsonian syndromes.
    Williams DR; Litvan I
    Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1189-212. PubMed ID: 24092286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders.
    Petsani C; Aloizou AM; Siokas V; Messinis L; Peristeri E; Bakirtzis C; Nasios G; Dardiotis E
    Behav Neurol; 2021; 2021():3419907. PubMed ID: 34976231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of atypical parkinsonian syndromes.
    Lo RY
    Tzu Chi Med J; 2022; 34(2):169-181. PubMed ID: 35465274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.
    Niccolini F; Politis M
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2244-2254. PubMed ID: 27470326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventional trials in atypical parkinsonism.
    Eschlböck S; Krismer F; Wenning GK
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S82-92. PubMed ID: 26421389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis across a cohort of "atypical" atypical and complex parkinsonism.
    Malaquias MJ; Igreja L; Nogueira C; Pereira C; Vilarinho L; Quelhas D; Freixo JP; Oliveira J; Magalhães M
    Parkinsonism Relat Disord; 2023 Jun; 111():105408. PubMed ID: 37105015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F; Barron DS; Tantiwongkosi B; Fox P
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological update: non-motor symptoms in atypical parkinsonian syndromes.
    Ananthavarathan P; Patel B; Peeros S; Obrocki R; Malek N
    J Neurol; 2023 Sep; 270(9):4558-4578. PubMed ID: 37316556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into atypical parkinsonism.
    Wenning GK; Krismer F; Poewe W
    Curr Opin Neurol; 2011 Aug; 24(4):331-8. PubMed ID: 21577106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical parkinsonian syndromes in a North African tertiary referral center.
    Nasri A; Ben Djebara M; Sghaier I; Mrabet S; Zidi S; Gargouri A; Kacem I; Gouider R
    Brain Behav; 2021 Jan; 11(1):e01924. PubMed ID: 33179436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Striatal Metabolism in [
    Seiffert AP; Gómez-Grande A; Alonso-Gómez L; Méndez-Guerrero A; Villarejo-Galende A; Gómez EJ; Sánchez-González P
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism plus syndrome--a review.
    Mitra K; Gangopadhaya PK; Das SK
    Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
    Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
    Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of atypical Parkinson syndromes.
    Höglinger GU; Kassubek J; Csoti I; Ehret R; Herbst H; Wellach I; Winkler J; Jost WH
    J Neural Transm (Vienna); 2017 Aug; 124(8):997-1004. PubMed ID: 28243754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety.
    Artusi CA; Rinaldi D; Balestrino R; Lopiano L
    Parkinsonism Relat Disord; 2022 Mar; 96():109-118. PubMed ID: 35288028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.